Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Current Opinion in Oncology|September 11, 2024
Lung cancer screening in never smokersGillianne G Y Lai, Daniel S W TanNature Reviews. Clinical Oncology|November 15, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.Nature Reviews. Clinical Oncology|November 29, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.Cancer Treatment Reviews|September 15, 2022
Refining patient selection of MET-activated non-small cell lung cancer through biomarker precisionGillianne G Y Lai, Robin Guo, Alexander Drilon, et al.JTO Clinical and Research Reports|January 1, 2024
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate MeasureStephanie P L Saw, Gek San Tan, Wei Chong Tan, et al.Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular AlterationsAaron C Tan, Daniel S W TanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2026
Rethinking Molecular Profiling Post First-Line OsimertinibKomal Gupta, Daniel S W Tan, Regina HooBMC Cell Biology|July 4, 2002
Nucleolar localization of an isoform of the IGF-I precursorDaniel S-W Tan, Alexandra Cook, Shern L ChewChinese Clinical Oncology|July 18, 2019
Challenges and insights of early phase oncology drug development in the Asia-Pacific regionHerbert H Loong, Daniel S W Tan, Toshio ShimizuPageof 13